CCDC6 and lung cancer: In this work, we demonstrated that the transient expression of the CCDC6 lung mutant or truncated isoforms in lung cancer cells determined a trend of cis-platinum resistance and Olaparib sensitivity as previously observed in the same cells stably silenced for CCDC6 [16].